All In Biotech

Drug Trial Radar · NCT04724369

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

A Prospective Phase 3 Multi-center Study to Assess the Efficacy and Safety of 18F-mFBG PET Imaging in Subjects With Neuroblastoma

Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

43

Actual

Start

Nov 18, 2021

Primary completion

Jul 30, 2026

Study completion Aug 30, 2026

Sponsor

Sponsor type
Industry
Collaborators
New Approaches to Neuroblastoma Therapy Consortium; Memorial Sloan Kettering Cancer Center
First posted
Jan 26, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3 study evaluating the positron-emitting radiopharmaceutical 18F-mFBG as an imaging agent for confirming or excluding the presence of neuroblastoma

Conditions

  • Neuroblastoma

Interventions

  • 18F-MFBGDrug

    Positron-emitting tomography (PET) (either PET/CT or PET/MR) imaging agent

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PET Scan Identification of NeuroblastomaTime frame: Imaging at 60 minutes

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital Los Angeles

    Los Angeles, California

  • University of California, San Francisco

    San Francisco, California

  • Riley Hospital for Children - Indiana University

    Indianapolis, Indiana

  • Dana-Farber Cancer Institute

    Boston, Massachusetts

  • University of Michigan Health System

    Ann Arbor, Michigan

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.